ARTICLE | Clinical News
Spiriva Respimat tiotropium bromide: Phase III data
September 19, 2016 7:00 AM UTC
Top-line data from the double-blind, international Phase III CanoTinA-asthma trial in 401 patients ages 6-11 with moderate symptomatic asthma who were taking an inhaled corticosteroid with or without ...